Chapter 17. Chronic Obstructive Pulmonary Disease Medication Therapy Management Data Set
Which of the following host factors can influence the risk of developing COPD following exposure to environmental risk factors?
c. Occupational dusts and chemicals
d. Airway hyperresponsiveness
All of the following parameters are indicative of a patient who is "high risk" for future COPD exacerbations EXCEPT:
a. Daily use of both an LA beta2-agonist and anticholinergic bronchodilator.
b. Airflow limitation defined as "severe" (30% ? FEV1 < #x003C; 50% predicted).
c. Grade 3 airflow limitation.
d. A history of 1 COPD exacerbation in the previous 12 months.
Which of the following is a component of the goal of risk reduction for COPD patients?
a. Prevent and treat exacerbations
b. Improve exercise tolerance
c. Scheduled use of quick-relief medication
d. Reduce quick-relief medication use
Using living room language, which of the following can be explained to a patient as the "total amount of air you can breathe out in 1 second?"
Which of the following would be appropriate to include in the MAP for a COPD patient?
a. Spiriva (tiotropium bromide) is a controller inhaler that may be used as needed to treat shortness of breath.
b. Use your Spiriva inhaler once every morning as prescribed (even on the days you wake up feeling well).
c. Advair (fluticasone/salmeterol) is a quick-relief inhaler that may be used as needed to treat shortness of breath.
d. If you experience shortness of breath during the day, use your Advair inhaler as prescribed for quick relief of your symptoms.
Which of the following is a symptom requiring IMMEDIATE referral to a physician?
a. Shortness of breath after climbing several flights of stairs that is relieved ...